Pure Global
NCT06254027

Clinical Investigation for the Evaluation of Efficacy and Safety of Two Medical Devices for Onychomycosis Treatment

Multicentric, Randomized, Evaluator Blinded Clinical Investigation for the Evaluation of Efficacy and Safety of Two Medical Devices for the Treatment of Onychomycosis
Oystershell NV·ClinicalTrials.gov·device·Device trialNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Onychomycosis
Drug/Device/Intervention
Forte
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Oystershell NV
Timeline & enrollment
Phase
N/A
Start date
Mar 01, 2024
End date
Sep 01, 2025
Enrollment
132 participants
Primary outcome

Percentage of healthy surface (Performance)

Summary

The goal of this clinical trial is to evaluate the effectiveness of FORTE, ACTIVE COVER LIGHT
 and Loceryl® in the treatment of onychomycosis based on the blinded evaluation of the
 percentage of healthy nail surface compared to baseline.

ICD-10 classifications
OnychogryphosisChromomycosis, unspecifiedOnycholysisActinomycosisBlastomycosis
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06254027
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06254027 through Pure Global AI's free database. This phase not specified trial is sponsored by Oystershell NV and is currently Not yet recruiting. The study focuses on Onychomycosis. Target enrollment is 132 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.